Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Charles River Laboratories International, Inc. Common Stock (NY: CRL )

165.57 +3.93 (+2.43%)
Official Closing Price Updated: 7:00 PM EST, Jan 30, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 896,172
Open 164.00
Bid (Size) 161.64 (2)
Ask (Size) 178.29 (1)
Prev. Close 161.64
Today's Range 161.69 - 166.20
52wk Range 159.65 - 275.00
Shares Outstanding 50,396,622
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Charles River Laboratories Schedules Fourth-Quarter 2024 Earnings and 2025 Guidance Release and Conference Call
From Charles River Laboratories International, Inc.
Via Business Wire
What Analysts Are Saying About Charles River Stock
Via Benzinga

Performance

YTD
-9.35%
-9.35%
1 Month
-10.31%
-10.31%
3 Month
-7.29%
-7.29%
6 Month
-31.82%
-31.82%
1 Year
-23.45%
-23.45%

More News

Read More
This STMicroelectronics Analyst Turns Bearish; Here Are Top 5 Downgrades For Wednesday
Via Benzinga
Charles River Expands Apollo™ Ecosystem, Offering Bespoke Client Experiences
From Charles River Laboratories International, Inc.
Via Business Wire
P/E Ratio Insights for Charles River
Via Benzinga
Evaluating Charles River: Insights From 12 Financial Analysts
Via Benzinga
This Spotify Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday
Via Benzinga
Charles River and Akron Bio Announce Collaboration to Enhance Operations with Integration of CGMP Materials into Cell Therapy Platform
From Charles River Laboratories International, Inc.
Via Business Wire
US Stocks Edge Higher As Traders Eye Inflation Data And Earnings Season Kickoff
Via Talk Markets
Topics Economy Stocks / Equities
Exposures Interest Rates
Charles River Laboratories to Present at J.P. Morgan Healthcare Conference
From Charles River Laboratories International, Inc.
Via Business Wire
The Analyst Verdict: Charles River In The Eyes Of 10 Experts
Via Benzinga
Charles River Introduces Global Biotech Incubator Program
From Charles River Laboratories International, Inc.
Via Business Wire
Charles River Laboratories to Present at Evercore ISI Investor Conference
From Charles River Laboratories International, Inc.
Via Business Wire
Charles River Laboratories to Present at UBS and Jefferies Conferences
From Charles River Laboratories International, Inc.
Via Business Wire
Charles River Q3 Earnings: CEO Notes Improved Biotech Funding And Stabilizing Demand - Here's Why
Via Benzinga
S&P 500, Dow Hit Record Highs After Trump Win; Fear Index Drops 20%
Via Benzinga
Topics Government Stocks
Exposures Political US Equities
Charles River Laboratories Announces Third-Quarter 2024 Results
From Charles River Laboratories International, Inc.
Via Business Wire
This Ferguson Enterprises Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday
Via Benzinga
Charles River Launches New Retrogenix® Non-Human Protein Library
From Charles River Laboratories International, Inc.
Via Business Wire
Charles River Laboratories Schedules Third-Quarter 2024 Earnings Release and Conference Call
From Charles River Laboratories International, Inc.
Via Business Wire
This Alibaba Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday
Via Benzinga
This Netflix Analyst Turns Bearish; Here Are Top 5 Downgrades For Monday
Via Benzinga
Charles River Provides Translational Expertise at Neuroscience 2024
From Charles River Laboratories International, Inc.
Via Business Wire
Charles River and Lundbeck Enter Agreement Utilizing AI-Powered Logica® to Advance the Discovery of Novel Drugs for Neurological Disease
From Charles River Laboratories International, Inc.
Via Business Wire
Charles River Laboratories and CEBINA Announce Strategic Collaboration to Accelerate Cutting Edge Neuroscience Research
From Charles River Laboratories International, Inc.
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.